
    
      Watson Laboratories, Inc. has developed a generic formulation of Clindamycin Phosphate and
      Benzoyl Peroxide Gel, 1.2%/2.5%,and the current study is designed to evaluate the safety and
      efficacy of this formulation to determine if it is bioequivalent to Acanya.
    
  